Embla Medical hf. (OSSFF)
OTCMKTS · Delayed Price · Currency is USD
4.850
0.00 (0.00%)
At close: Feb 9, 2026
Embla Medical Market Cap
Embla Medical has a market cap or net worth of $2.04 billion as of February 12, 2026. Its market cap has decreased by -0.03% in one year.
Market Cap
2.04B
Enterprise Value
2.49B
Revenue
928.69M
Ranking
n/a
PE Ratio
24.53
Stock Price
$4.85
Market Cap Chart
Since September 4, 2009, Embla Medical's market cap has increased from 444.74M to 2.04B, an increase of 359.73%. That is a compound annual growth rate of 9.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.04B | -6.53% |
| Dec 30, 2025 | 2.19B | 3.42% |
| Dec 30, 2024 | 2.12B | 23.63% |
| Dec 29, 2023 | 1.71B | -15.52% |
| Dec 30, 2022 | 2.03B | -25.54% |
| Dec 30, 2021 | 2.72B | -19.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 340.99M |
| Tian'an Technology Group | 182.07M |
| Zomedica | 127.39M |
| Positron | 68.49M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 55.94M |
| Guided Therapeutics | 33.69M |
| Vivos | 33.66M |